Aggregated low density lipoproteins decrease metalloproteinase-9 expression and activity in human coronary smooth muscle cells

Atherosclerosis

Volumn 194, Issue 2, 2007, Pages 326-333

  Otero Viñas, Marta ^a   Llorente Cortés, Vicenta ^a   Peña, Ester ^a   Padró, Teresa ^a   Badimon, Lina ^a  

^a Institut Català de Ciències Cardiovasculars   (Spain)

Author keywords

Aggregated LDL; Metalloproteinase 9; Migration; Vascular smooth muscle cells

Indexed keywords

GELATINASE A; GELATINASE B; LOW DENSITY LIPOPROTEIN; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

ARTICLE; ATHEROSCLEROTIC PLAQUE; CELL DAMAGE; CELL GROWTH; CELL MIGRATION; CONTROLLED STUDY; CORONARY ARTERY; DOWN REGULATION; ENZYME ACTIVITY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SMOOTH MUSCLE FIBER;

CELL MOVEMENT; CELLS, CULTURED; CORONARY VESSELS; DOWN-REGULATION; HUMANS; LIPOPROTEINS, LDL; MATRIX METALLOPROTEINASE 9; MICROSCOPY, CONFOCAL; MYOCYTES, SMOOTH MUSCLE; WOUND HEALING;

EID: 34848843012     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2006.10.021     Document Type: Article

References (34)

1. Ross R. Cell biology and atherosclerosis. Annu Rev Physiol 57 (1995) 791-804
2. Plutzky J. Atherosclerotic plaque rupture: emerging insights and opportunities. Am J Cardiol 84 (1999) 15J-20J
3. Mason D.P., Kenagy R.D., Hasenstab D., et al. Matrix metalloproteinase-9 overexpression enhances vascular smooth muscle cell migration and alters remodeling in the injured rat carotid artery. Circ Res 85 (1999) 1179-1185
4. Newby A.C. Dual role of matrix metalloproteinases (matrixins) in intimal thickening and atherosclerotic plaque rupture. Physiol Rev 85 (2005) 1-31
5. Ha K.T., Lee T.K., Kwak K.H., et al. Inhibitory effect of Cho-Deung-San on human aortic smooth muscle cell migration induced by TNF-α through inhibition of matrix metalloproteinase-2 and -9 activity. Vasc Pharmacol 41 (2004) 83-90
6. Johnson J.L., van Eys G.J.J.M., Angelini G.D., and George S.J. Injury induces dedifferentiation of smooth muscle cells and increased matrix-degrading metalloproteinase activity in human saphenous vein. Arterioscler Thromb Vasc Biol 21 (2001) 1146-1151
7. Gomez D.E., Alonso D.F., Yoshiji H., and Thorgeirsson U.P. Tissue inhibitors of metalloproteinases: structure, regulation and biological functions. Eur J Cell Biol 74 (1997) 111-122
8. George S.J. Tissue inhibitors of metalloproteinases and metalloproteinases in atherosclerosis. Curr Opin Lipidol 9 (1998) 413-423
9. Galis Z.S., and Khatri J.J. Matrix metalloproteinases in vascular remodeling and atherogenesis: the good, the bad, and the ugly. Circ Res 90 (2002) 251-262
10. Johnson J.L., George S.J., Newby A.C., and Jackson C.L. Divergent effects of matrix metalloproteinases 3, 7, 9, and 12 on atherosclerotic plaque stability in mouse brachiocephalic arteries. PNAS 102 (2005) 15575-15580
11. Cho A., and Reidy M.A. Matrix metalloproteinase-9 is necessary for the regulation of smooth muscle cell replication and migration after arterial injury. Circ Res 91 (2002) 845-851
12. Galis Z.S., Johnson C., Godin D., et al. Targeted disruption of the matrix metalloproteinase-9 gene impairs smooth muscle cell migration and geometrical arterial remodeling. Circ Res 91 (2002) 852-859
13. Matrisian L.M. Metalloproteinases and their inhibitors in matrix remodeling. Trends Genet 6 (1990) 121-125
14. Moreau M., Brocheriou I., Petit L., Ninio E., Chapman M.J., and Rouis M. Interleukin-8 mediates downregulation of tissue inhibitor of metalloproteinase-1 expression in cholesterol-loaded human macrophages. Circulation 99 (1999) 420-426
15. Kullo I.J., Edwards E.D., and Schwartz R.S. Vulnerable plaque: pathobiology and clinical implications. Ann Intern Med 129 (1998) 1050-1060
16. Theilmeier G., Quarck R., Verhamme P., et al. Hypercholesterolemia impairs vascular remodeling after porcine coronary angioplasty. Cardiovasc Res 55 (2002) 385-395
17. Wilson D., Massaeli H., Pierce G.N., and Zahradka P. Native and minimally oxidized low density lipoprotein depress smooth muscle matrix metalloproteinase levels. Mol Cell Biochem 249 (2003) 141-149
18. Ardans J.A., Economou A.P., Martinson Jr. J.M., Zhou M., and Wahl L.M. Oxidized low-density and high-density lipoproteins regulate the production of matrix metalloproteinase-1 and -9 by activated monocytes. J Leukoc Biol 71 (2002) 1012-1018
19. Xu X.P., Meisel S.R., Ong J.M., et al. Oxidized low-density lipoprotein regulates matrix metalloproteinase-9 and its tissue inhibitor in human monocyte-derived macrophages. Circulation 99 (1999) 993-998
20. Lee K.J., Kim H.A., Kim P.H., et al. Ox-LDL suppresses PMA-induced MMP-9 expression and activity through CD36-mediated activation of PPAR-γ. Exp Mol Med 36 (2004) 534-544
21. Frank J.S., and Fogelman A.M. Ultrastructure of the intima WHHL and cholesterol-fed rabbit aortas prepared by ultra rapid freezing and freeze-etching. J Lipid Res 30 (1989) 867-978
22. Camejo G., Fager G., Rosengren B., Hurt-Camejo E., and Bondjers G. Binding of low density lipoproteins by proteoglycans synthesized by proliferating and quiescent human arterial smooth muscle cells. J Biol Chem 268 (1993) 14131-14137
23. Steele R., and Wagner W. Lipoprotein interaction with artery wall derived proteoglycan: comparisons between atherosclerosis-susceptible WC-2 and resistant Show Racer pigeons. Atherosclerosis 65 (1987) 63-73
24. Llorente-Cortés V., Martínez-González J., and Badimon L. LDL receptor-related protein mediates uptake of aggregated LDL in human vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 20 (2000) 1572-1579
25. Llorente-Cortés V., Otero-Viñas M., Hurt-Camejo E., Martínez-González J., and Badimon L. Human coronary smooth muscle cells internalize versican-modified LDL through LDL receptor-related protein and LDL receptors. Arterioscler Thromb Vasc Biol 22 (2002) 387-393
26. Llorente-Cortés V., Otero-Viñas M., Camino-Lopez S., Costales P., and Badimon L. Cholesteryl esters of aggregated LDL are internalized by selective uptake in human vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 26 (2006) 117-123
27. Basu S.K., Goldstein J.L., Anderson G.W., and Brown M.S. Degradation of cationized low density lipoprotein and regulation of cholesterol metabolism in homozygous familial hypercholesterolemia fibroblasts. Proc Natl Acad Sci 73 (1976) 3178-3182
28. Llorente-Cortés V., Otero-Viñas M., Sanchez S., Rodriguez C., and Badimon L. Low-density lipoprotein upregulates low-density lipoprotein receptor-related protein expression in vascular smooth muscle cells: possible involvement of sterol regulatory element binding protein-2-dependent mechanism. Circulation 106 (2002) 3104-3110
29. Arguinzonis M.I.G., Galler A.B., Walter U., Reinhard M., and Simm A. Increased spreading, Rac/p21-activated kinase (PAK) activity, and compromised cell motility in cells deficient in vasodilator-stimulated phosphoprotein (VASP). J Biol Chem 277 (2002) 45604-45610
30. de Villiers W.J., and Smart E.J. Macrophage scavenger receptors and foam cell formation. J Leukoc Biol 66 (1999) 740-746
31. Steinbrecher U.P. Receptors for oxidized low density lipoprotein. Biochim Biophys Acta 1436 (1999) 279-298
32. Brown M.S., and Goldstein J.L. Familial hypercholesterolemia: a genetic defect in the low-density lipoprotein receptor. New Engl J Med 294 (1976) 1386-1390
33. Fabunmi R.P., Sukhova G.K., Sugiyama S., and Libby P. Expression of tissue inhibitor of metalloproteinases-3 in human atheroma and regulation in lesion-associated cells: a potential protective mechanism in plaque stability. Circ Res 83 (1998) 270-278
34. Llorente-Cortés V., Otero-Viñas M., Berrozpe M., and Badimon L. Intracellular lipid accumulation, low-density lipoprotein receptor-related protein expression, and cell survival in vascular smooth muscle cells derived from normal and atherosclerotic human coronaries. Eur J Clin Invest 34 (2004) 182-190